MENU
Aim higher

PAT

Psoriasis Anti-inflammatory Treatment

The project will extensively test a TLR7–specific anti-inflammatory compound, TMX-302, in established animal models of psoriasis. The objective being to acquire the knowledge base needed to proceed on pre-clinical studies and clinical trials for a new effective and safe treatment of psoriasis.
Acronym: 
PAT
Project ID: 
7 783
Ranking: 
93
Cut-off: 
9
Start date: 
01-09-2013
Project Duration: 
40months
Project costs: 
1 374 560.00€
Technological Area: 
Pharmaceutical Products / Drugs
Market Area: 
Pharmaceuticals/fine chemicals